Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
about
Expression of tumor-rejection antigens in gynecologic cancersCytokines required for induction of histocompatibility leukocyte antigen-class I-restricted and tumor-specific cytotoxic T lymphocytes by a SART1-derived peptideSerine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsExpression of tumor rejection antigens in colorectal carcinomasExpression of SART3 antigen and induction of CTLs by SART3-derived peptides in breast cancer patientsRecognition of the Lck tyrosine kinase as a tumor antigen by cytotoxic T lymphocytes of cancer patients with distant metastases.Cancer/testis antigens: structural and immunobiological properties.Immunotherapeutic strategies for malignant glioma.A phase I trial of cytotoxic T-lymphocyte precursor-oriented peptide vaccines for colorectal carcinoma patientsUpdate on vaccine development for renal cell cancer.Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.Dendritic Cells Promoted by Ginseng Saponins Drive a Potent Th1 Polarization.P53, hTERT, WT-1, and VEGFR2 are the most suitable targets for cancer vaccine therapy in HLA-A24 positive pancreatic adenocarcinoma.Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma.Effective screening of T cells recognizing neoantigens and construction of T-cell receptor-engineered T cells.Expression of the tumor-rejection antigen SART1 in brain tumors.
P2860
Q28138549-F059048D-70E7-4ED2-AFD4-32C53857B014Q28146219-BB12D533-4090-48EF-8D96-85C03EA633DDQ28202640-93EFACC3-81A6-486C-84AF-1F050F72E6F4Q28211063-A5A4AB03-29C7-4657-8716-066CFFC02B7CQ28361963-DF68A5E3-0C0A-400F-99A3-CE37553D384FQ31946820-7E6FF153-FDDF-4A59-A493-A3A285CB5EC0Q34568997-70633DF7-B321-497A-88A1-6E0EFE589FA3Q35778576-48009656-B029-4FBA-9F2C-EDC0BA6D1053Q36694874-2B38FF9D-0B7C-4560-8C54-4C30455482D3Q36989720-A6B8C80C-2C24-4A14-AADC-A7B7366B6EF1Q40812116-C815270E-091A-4DCA-BD36-2B87FD8DA9CAQ42176450-2370F3FC-CC79-45F4-819B-C49C3ED2DB5EQ44269708-CC0023AF-E6E5-46D5-98A2-0FD4F82B648BQ51013344-1AB5E437-19BF-415E-BC3D-3FD54F4A8E5CQ55011828-256D066C-C286-4547-8DEA-C21CA246F3BFQ55476322-218057DE-FBA4-4C3A-8A4C-F114C3482F51
P2860
Identification of a SART-1-derived peptide capable of inducing HLA-A24-restricted and tumor-specific cytotoxic T lymphocytes
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@ast
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@en
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@en-gb
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@nl
type
label
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@ast
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@en
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@en-gb
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@nl
prefLabel
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@ast
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@en
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@en-gb
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@nl
P2093
P2860
P921
P1476
Identification of a SART-1-der ...... ecific cytotoxic T lymphocytes
@en
P2093
K Matsunaga
S Shichijo
P2860
P304
P356
10.1002/(SICI)1097-0215(19990505)81:3<459::AID-IJC21>3.0.CO;2-6
P407
P577
1999-05-05T00:00:00Z